Hiroaki Kimura
Corporate Officer/Principal at H.U. GROUP HOLDINGS, INC.
Hiroaki Kimura active positions
| Companies | Position | Start | End |
|---|---|---|---|
| H.U. GROUP HOLDINGS, INC. | Corporate Officer/Principal | 2021-06-22 | - |
| Chief Administrative Officer | 2012-05-31 | 2015-07-06 | |
| Chief Tech/Sci/R&D Officer | 2012-05-31 | 2021-06-22 | |
| Investor Relations Contact | 2011-06-30 | - | |
| Public Communications Contact | 2011-06-30 | 2019-06-20 | |
| Fuji SC Bio KK | Director/Board Member | 2005-05-31 | - |
Career history of Hiroaki Kimura
Former positions of Hiroaki Kimura
| Companies | Position | Start | End |
|---|---|---|---|
Advanced Life Science Institute KK
 Advanced Life Science Institute KK Pharmaceuticals: MajorHealth Technology Advanced Life Science Institute KK manufactures and wholesales testing drugs for hepatitis viruses and lung cancers. The company is based in Tokyo, Japan and was founded in 1997. | Director/Board Member | 2010-05-31 | - |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Director/Board Member | 2011-10-31 | - |
Fujirebio Taiwan, Inc.
 Fujirebio Taiwan, Inc. Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Taiwan, Inc. develops, manufactures and distributes pharmaceutical products. The company is based in Taoyuan, Taiwan. | Director/Board Member | 2010-05-31 | - |
Fujirebio, Inc.
 Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Director/Board Member | 2009-05-31 | - |
Statistics
International
| Japan | 5 |
| Belgium | 2 |
| Taiwan | 2 |
Operational
| Director/Board Member | 5 |
| Chief Administrative Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 5 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| H.U. GROUP HOLDINGS, INC. | Health Services |
| Private companies | 5 |
|---|---|
| Fuji SC Bio KK | |
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Fujirebio Taiwan, Inc.
Fujirebio Taiwan, Inc. Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Taiwan, Inc. develops, manufactures and distributes pharmaceutical products. The company is based in Taoyuan, Taiwan. | Health Technology |
Advanced Life Science Institute KK
Advanced Life Science Institute KK Pharmaceuticals: MajorHealth Technology Advanced Life Science Institute KK manufactures and wholesales testing drugs for hepatitis viruses and lung cancers. The company is based in Tokyo, Japan and was founded in 1997. | Health Technology |
- Stock Market
- Insiders
- Hiroaki Kimura
- Experience
